Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) in North Carolina
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in North Carolina
| Provider | Medicare | Services |
|---|---|---|
| Laboratory Corporation Of America... | $172.44 | 387 |
North Carolina Pricing in Context
In North Carolina, CPT code 0014M (Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test)) carries an average Medicare payment of $172.44 — 0% above the national benchmark of $172.16. 1 providers across the state submitted claims for this procedure in 2023, performing 387 total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in North Carolina is $505.67, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Other procedures, the estimated commercial insurance price in North Carolina lands near $375.92, with self-pay cash prices typically around $268.39. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) cost in North Carolina?
The average Medicare payment for Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) in North Carolina is $172.44, which is 0% above the national average of $172.16. Providers in NC typically bill $505.67 for this procedure.
What does Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) cost with insurance in North Carolina?
With commercial insurance in North Carolina, Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) costs an estimated $375.92. Without insurance, the estimated cash price is $268.39. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) in North Carolina?
1 providers in North Carolina billed Medicare for Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) in 2023, performing 387 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) cheaper in North Carolina than the national average?
No — Molecular Pathology Test For Risk Of Serious Liver Disease Within 5 Years (enhanced Liver Fibrosis (elf) Test) costs 0% above the national average in North Carolina. The state average Medicare payment is $172.44 compared to $172.16 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.